Spicy Queso Blanco Creamy White Queso with Jalapeños and Habanero Heat Ingredients: 1 tablespoon butter 1 tablespoon finely chopped onion 1 jalapeño pepper, finely chopped (seeds removed for less heat) 1 small habanero pepper, minced (optional for extra spice) 2 tablespoons all-purpose flour 1 cup whole milk 1/2 cup heavy cream 2 cups shredded white American cheese 1/2 cup shredded Monterey Jack cheese 1/4 teaspoon garlic powder Salt to taste 2 tablespoons chopped cilantro (optional) Diced tomatoes or pico de gallo for topping (optional) Directions: In a medium saucepan, melt the butter over medium heat. Add the chopped onion, jalapeño, and habanero. Sauté for 2–3 minutes until fragrant and softened. Stir in the flour and cook for 1 minute, whisking constantly to form a roux. Slowly pour in the milk and heavy cream while whisking to prevent lumps. Continue whisking until the mixture begins to thicken, about 3–5 minutes. Reduce heat to low and add the white American and Monterey Jack cheeses gradually, stirring until smooth and fully melted. Stir in garlic powder and salt to taste. Add chopped cilantro if using. Transfer to a serving bowl and top with diced tomatoes or pico de gallo for color and flavor. Serve warm with tortilla chips or as a topping for tacos, nachos, or burritos. Prep Time: 10 minutes | Cooking Time: 10 minutes | Total Time: 20 minutes Kcal: 210 kcal per serving | Servings: 6 servings #queso #quesoblanco #spicydip #cheesedip #texmexflavors #partyappetizer #gamedaysnack #cheeselovers #jalapenoheat #meltycheese #appetizerideas #habanerocheese #mexicancheese #nachodip #cheesysnack #spicyqueso #dipparty #snackattack #homemadequeso #creamyandspicy This Spicy Queso Blanco is ultra-creamy with a fiery kick from jalapeño and habanero—perfect for your next party or Netflix binge!

In a historic medical milestone, the world’s first mRNA-based lung cancer vaccine, BNT116, has entered human clinical trials across seven countries. Developed by BioNTech, the same company behind one of the leading COVID-19 vaccines, this breakthrough treatment targets non-small cell lung cancer (NSCLC) — the most common and deadliest type of lung cancer. The vaccine is designed to train the immune system to recognize and destroy cancer cells, offering a more targeted and less toxic alternative to conventional therapies. Currently in Phase 1 clinical trials, the vaccine is being tested on about 130 patients, including participants in the UK, Germany, Spain, and the U.S. The early-stage trials aim to assess safety and immune response, with hopes of preventing cancer recurrence in previously treated patients. If successful, BNT116 could revolutionize how we approach lung cancer — shifting treatment from chemotherapy to a personalized, immune-driven solution. The race toward a cancer vaccine future is officially underway. #LungCancerVaccine #BioNTech #CancerResearch #mRNAtechnology #CancerBreakthrough

Thiên Bình tụi tui không thích lặp lại. Thiên Bình là vậy. Thay đổi là chuyện ngoài da. Mỗi event là một vibe mới, nhưng vẫn là một tui cũ – biết yêu thương, biết giữ lời, và biết ai đáng để trân trọng. Ai cùng vibe vô điểm danh thử coi có đúng hong? 🤪😎 #ngoctrinh #ngoctrinh89 #fanci

The world’s first lung cancer vaccine, known as CIMAvax-EGF, has entered clinical trials in seven countries, marking a major milestone in cancer treatment. Unlike preventive vaccines, this is a therapeutic vaccine designed to treat existing lung cancer by targeting and neutralizing epidermal growth factor (EGF) — a protein that promotes the growth of cancer cells. Developed in Cuba, the vaccine has already shown promising results in extending survival for patients with advanced non-small cell lung cancer (NSCLC). Now, international clinical trials are being launched in the United States, United Kingdom, Japan, Cuba, Serbia, Bosnia and Herzegovina, and Colombia. The U.S. trials are being led by Roswell Park Comprehensive Cancer Center in partnership with Cuban researchers. This groundbreaking collaboration could offer a new path forward in cancer immunotherapy, particularly for one of the deadliest cancers globally. If successful, the vaccine may significantly improve outcomes and quality of life for lung cancer patients around the world.

The Alaskan wood frog (Lithobates sylvaticus) has one of the most extraordinary survival strategies in the animal kingdom. During the harsh Alaskan winters, this frog freezes solid — meaning its heart stops beating, it stops breathing, and up to 70% of its body water turns to ice. Its body essentially shuts down. To survive this freeze, the frog produces high concentrations of glucose and urea in its vital organs, acting like antifreeze to protect cells from damage. These compounds prevent ice crystals from forming inside the cells, which would otherwise be lethal. Instead, ice forms in the spaces outside the cells. As temperatures rise in spring, the frog thaws out. Remarkably, it resumes its heartbeat, breathing, and normal bodily functions within a day or two, effectively "coming back to life." This phenomenon is a remarkable example of cryobiology and is of great interest to scientists studying cryopreservation and organ transplantation. This adaptation allows the wood frog to thrive farther north than any other North American amphibian — even above the Arctic Circle.